Join the largest and longest-running summit on market access in Canada. Gain direct feedback from regulators, public and private payers and patient groups to improve your access. Get new information on:
Develop a blueprint to improve your submissions and increase patient access to treatments. Register now!
Louis Thériault joined Innovative Medicines Canada in April 2018. Reporting to the President, he is responsible for the development of a comprehensive and forward-looking health policy strategy driven by evidence-based research. Louis is also focused on building and strengthening partnerships for effective policy implementation which enhance health systems performance and the competitiveness of the Canadian life science sector.
Louis has over 25 years of experience in economic research in the field of Public Policies. Before joining Innovative Medicines Canada, he held an executive role at the Conference Board of Canada leading a team of 40 researchers and professionals as the Vice President, Industry Strategy and Public Policy. Louis joined the Conference Board in 1997 and launched, managed, expanded and provided strategic direction for several lines of business including the Canadian Alliance for Sustainable Health Care (CASHC); the International Trade and Investment Centre; the Canadian Industrial Outlook Service; and the Metropolitan Outlook Service. Louis leveraged the quantitative analysis skills of the economic and forecast analysis team with the organizational performance and public policy expertise within the Conference Board to ensure success. Most recently, he launched the Board’s Health Economics Group, providing forward-looking, quantitative analysis of the sustainability of the Canadian healthcare system. Louis holds a Master’s Degree in Economics from Université Laval and is fluently bilingual.
Louis is recognized for his leadership, strategic thinking, initiative and organizational skills which positions him to add value in moving Canadian pharmaceutical policy issues forward on behalf of Innovative Medicines Canada’s members.
Jeremy Slobodan is the Director, Drug Utilization, Information & Stewardship for Alberta Health Services and is based out of Red Deer. His position oversees the AHS drug formulary, drug information and antimicrobial stewardship for Pharmacy Services.
In part, his role includes improving patient care through optimized drug use and working with practitioners to ensure new drugs introduced onto the AHS formulary provide improvements to the health care system.
Jeremy is the Chair of the National Hospital Formulary Collaborative, a member of the Alberta Health Expert Committee on Drug Evaluation & Therapeutics and a past president of the Alberta Pharmacists Association."
Sylvie Bouchard holds a bachelor’s degree in Pharmacy from Université Laval in Québec city (1988). She also has a diploma (1989) and a master’s degree (1992) in Hospital Pharmacy from Université Laval (Faculty of Pharmacy), and an MBA in Corporate Management (2001), also from Université Laval (Faculty of Business Administration).
Sylvie Bouchard was a hospital pharmacist and hospital pharmacy manager, first at the Centre hospitalier affilié universitaire de Québec (CHA), from 1988 to 2004, then at the Hôtel-Dieu de Québec, part of the Centre hospitalier universitaire de Québec (CHUQ), from 2006 to 2010. She has worked in several clinical departments and shown a strong interest in intensive care. In 2001, Ms. Bouchard introduced to the CHA new automation and distribution technologies for medications.
She joined the Conseil du médicament in April 2010, which became the Institut national d’excellence en santé et en services sociaux (INESSS) in 2011, where she has held various management positions over the years. Since April 2016, she has headed the Direction du médicament, a role involving the evaluation of medications for inclusion on the lists, the optimal use of drug products and collective prescriptions.
